Citigroup Maintains Buy on Exact Sciences, Raises Price Target to $100

Benzinga · 05/11/2023 10:43
Citigroup analyst Patrick Donnelly maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $90 to $100.